QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cbdmd-announces-new-partnership-with-bevtalk-distribution-to-expand-herbal-oasis-thc-seltzer-distribution-across-florida

cbdMD, Inc. (NYSE:YCBD), one of the most trusted and recognized cannabidiol (CBD) brands in the United States with a comprehens...

 on-september-30-2025-cbdmd-entered-into-securities-purchase-agreements-with-four-institutional-investors-for-17m-through-17m-series-b-convertible-preferred-stock

Effective September 30, 2025, cbdMD, Inc. (the "Company") entered into Securities Purchase Agreements dated September 2...

Core News & Articles

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

Core News & Articles

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

 maxim-group-maintains-buy-on-cbdmd-lowers-price-target-to-2

Maxim Group analyst Tom McGovern maintains cbdMD (AMEX:YCBD) with a Buy and lowers the price target from $3 to $2.

 cbdmd-q3-eps-021-up-from-893-yoy-sales-4607m-miss-5303m-estimate

cbdMD (AMEX:YCBD) reported quarterly losses of $(0.21) per share. This is a 97.65 percent increase over losses of $(8.93) per s...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION